BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Lin Q, Song C, Ma R, Li X. Depletion of circ_0007841 inhibits multiple myeloma development and BTZ resistance via miR-129-5p/JAG1 axis. Cell Cycle 2020;19:3289-302. [PMID: 33131409 DOI: 10.1080/15384101.2020.1839701] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Luo Z, Yin Y, Tan X, Liu K, Chao Z, Xia H. Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis. Leuk Res 2021;113:106774. [PMID: 35030455 DOI: 10.1016/j.leukres.2021.106774] [Reference Citation Analysis]
2 Wang H, Shan S, Wang H, Wang X. CircATXN7 contributes to the progression and doxorubicin resistance of breast cancer via modulating miR-149-5p/HOXA11 pathway. Anticancer Drugs 2022;33:e700-10. [PMID: 34845164 DOI: 10.1097/CAD.0000000000001243] [Reference Citation Analysis]
3 Huang K, Liu D, Su C. Circ_0007841 accelerates ovarian cancer development through facilitating MEX3C expression by restraining miR-151-3p activity. Aging (Albany NY) 2021;13:12058-66. [PMID: 33896797 DOI: 10.18632/aging.202911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Fang W, Mu J, Yang Y, Liu L. CircRERE confers the resistance of multiple myeloma to bortezomib depending on the regulation of CD47 by exerting the sponge effect on miR-152-3p. J Bone Oncol 2021;30:100381. [PMID: 34307012 DOI: 10.1016/j.jbo.2021.100381] [Reference Citation Analysis]
5 Wang S, Qian L, Cao T, Xu L, Jin Y, Hu H, Fu Q, Li Q, Wang Y, Wang J, Xia Y, Huang X. Advances in the Study of CircRNAs in Tumor Drug Resistance. Front Oncol 2022;12:868363. [DOI: 10.3389/fonc.2022.868363] [Reference Citation Analysis]
6 Ma H, Shen L, Yang H, Gong H, Du X. Circular RNA circPSAP functions as an efficient miR-331-3p sponge to regulate proliferation, apoptosis and bortezomib sensitivity of human multiple myeloma cells by upregulating HDAC4. Journal of Pharmacological Sciences 2022. [DOI: 10.1016/j.jphs.2022.01.013] [Reference Citation Analysis]
7 Yu D, Hu M, Tian Q. KDM4C Promotes Proliferation and Migration of Multiple Myeloma Cells by Up-Regulating JAG1 Gene Expression. J hard tissue biol 2021;30:257-64. [DOI: 10.2485/jhtb.30.257] [Reference Citation Analysis]
8 Zhou S, Wang R. Targeted therapy of multiple myeloma. Exploration of Targeted Anti-tumor Therapy. [DOI: 10.37349/etat.2021.00057] [Reference Citation Analysis]
9 Gao Y, Huang Y. Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner. J Chemother 2022;:1-14. [PMID: 35380509 DOI: 10.1080/1120009X.2022.2056995] [Reference Citation Analysis]
10 Wu Z, Chen D, Rajakani K. MiR-129-5p Inactivates NF-κB Pathway to Block Rheumatoid Arthritis Development via Targeting BRD4. Journal of Healthcare Engineering 2022;2022:1-8. [DOI: 10.1155/2022/8330659] [Reference Citation Analysis]
11 Allegra A, Cicero N, Tonacci A, Musolino C, Gangemi S. Circular RNA as a Novel Biomarker for Diagnosis and Prognosis and Potential Therapeutic Targets in Multiple Myeloma. Cancers 2022;14:1700. [DOI: 10.3390/cancers14071700] [Reference Citation Analysis]